von Garnier, C

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 36.

Journal Article

Mühlethaler, K; Bögli-Stuber, K; Wasmer, S; von Garnier, C; Dumont, P; Rauch, A; Mühlemann, K; Garzoni, C (2012). Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. European respiratory journal, 39(4), pp. 971-8. Sheffield, UK: European Respiratory Society 10.1183/09031936.00095811

von Gunten, S; Marsland, B J; von Garnier, C; Simon, D (2012). Update in clinical allergy and immunology. Allergy, 67(12), pp. 1491-500. Oxford: Wiley-Blackwell 10.1111/all.12067

von Garnier, C; Rothen-Rutishauser, B; Fink, A (2012). A particular therapy. International Innovation.

Engler, K; Mühlemann, K; Garzoni, C; Pfahler, H; Geiser, T; von Garnier, C (2012). Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients. Swiss medical weekly, 142:0 Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13509

von Garnier, C; Geiser, T (2011). Comment on "Pre- and intra-operative mediastinal staging in non-small-cell lung cancer. Swiss medical weekly, Nov 21, p. 141. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13289

Fear, VS; Burchell, JT; Lai, SP; Wikstrom, ME; Blank, F; von Garnier, C; Turner, DJ; Sly, PD; Holt, PG; Strickland, DS; Stumbles, PA (2011). Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T Cell proliferation during the induction of inhalation tolerance. Journal of immunology, 187(9), pp. 4561-70. Bethesda, Md.: American Association of Immunologists 10.4049/jimmunol.1004189

Brill, AK; von Garnier, C (2011). "Vernebelungstaktik" gegen Lungenerkrankungen. Hausarztpraxis - Fortschritte der Medizin(6 - 7), 20 - 23. Zürich: Prime Public Media AG

Blank, F; Stumbles, Ph; von Garnier, C (2011). Opportunities and challenges of the pulmonary route for vaccination. Expert opinion on drug delivery, 8(5), pp. 547-63. London: Taylor & Francis 10.1517/17425247.2011.565326

Chhajed, PN; Odermatt, R; von Garnier, C; Chaudhari, P; Leuppi, JD; Stolz, D; Tamm, M (2011). Endobronchial ultrasound in hilar and conventional TBNA-negative / inconclusive mediastinal lymphadenopathy. Journal of cancer research and therapeutics, 7(2), pp. 148-51. Mumbai: Medknow Publications 10.4103/0973-1482.82930

Miedinger, D; Drescher, T; Nester, N; Zeller, A; von Garnier, C; Leuppi, JD (2011). Smoking behaviour and willingness to stop smoking in patients admitted in an internal medicine ward. Praxis - schweizerische Rundschau für Medizin, 27(100(9)), pp. 525-30. Bern: Huber 10.1024/1661-8157/a000516

Blank, F; Gerber, P; Rothen-Rutishauser, B; Sakulkhu, U; Salaklang, J; de Peyer, K; Gehr, P; Nicod, LP; Hofmann, H; Geiser, T; Petri-Fink, A; von Garnier, C (2011). Biomedical nanoparticles retain an immature like functional state and show reduced antigen specific CD4+ T cell stimulation in vitro. Nanotoxicology(Jan 2011) London: Informa Healthcare

Rothen-Rutishauser, B; Blank, F; Petri-Fink, A; Clift, MJ; Geiser, T; von Garnier, C (2011). Laser scanning microscopy combined with image restoration to analyse and quantify the intracellular localisation of fluorescently labelled nanoparticles. Imaging & microscopy Weinheim: GIT-Verlag

Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Geiser, T; Nicod, LP; von Garnier, C (2010). Dendritic cells exposed to biomedical nanoparticles retain an immature like functional state and show reduced antigen specific CD4+ T cell stimulation in vitro. American journal of respiratory and critical care medicine, 181(A3096) New York, N.Y.: American Lung Association

von Garnier, C; Nicod, LP (2009). Immunology taught by lung dendritic cells. Swiss medical weekly, 139(13-14), pp. 186-92. Muttenz: EMH Schweizerischer Ärzteverlag

Zosky, GR; Larcombe, AN; White, OJ; Burchell, JT; von Garnier, C; Holt, PG; Turner, DJ; Wikstrom, ME; Sly, PD; Stumbles, PA (2009). Airway hyperresponsiveness is associated with activated CD4+ T cells in the airways. American journal of physiology - lung cellular and molecular physiology, 297(2), pp. 373-9. Bethesda, Md.: American Physiological Society 10.1152/ajplung.00053.2009

von Garnier, C (2008). Akute Bronchitis - Differenzialdiagnose und Behandlungsstrategie. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(6), pp. 7-8. Neuhausen (CH): Rosenfluh

von Garnier, C; Wikstrom, ME; Zosky, G; Turner, DJ; Sly, PD; Smith, M; Thomas, JA; Judd, SR; Strickland, DH; Holt, PG; Stumbles, PA (2007). Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. Journal of immunology, -179(9), pp. 5748-59. Bethesda, Md.: American Association of Immunologists

von Garnier, C; Strickland, D; Stumbles, P (2007). Comment on "Local CD11c+ MHC Class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process". Journal of immunology, -178(5), p. 2609. Bethesda, Md.: American Association of Immunologists

Book Section

Stumbles, P; Andrus, P; McLellan, S; von Garnier, C (2008). Chronic asthma. Chronic illness & disability. In: (pp. 269-286). Amsterdam: Elsevier

von Garnier, C (2008). Solitary Pulmonary Nodule (Pulmonaler Rundherd). In: (pp. 390-392). D&F GmbH

von Garnier, C (2008). Cough (Husten). In: (pp. 376-381). D&F GmbH

Conference or Workshop Item

Blank, F; Strickland, DH; Stumbles, PA; Holt, PG; von Garnier, C (2012). Size-dependent particle uptake and trafficking by antigen presenting cells in different anatomical respiratory tract compartments. In: Annual meeting of the European Respiratory Society 2012. A - Vienna: Annual meeting of the European Respiratory Society 2012

Blank, F; Strickland, DH; Stumbles, PA; Holt, PG; von Garnier, C (2012). Nanocarrier size determines the respiratory tract antigen presenting cell population targeted. In: Jahresversammlung Schweizerische Gesellschaft für Pneumologie. Montana: Jahresversammlung Schweizerische Gesellschaft für Pneumologie

Blank, F; Strickland, DH; Stumbles, PA; Holt, PG; von Garnier, C (2012). Size determines particle uptake efficiency and trafficking by prominent respiratory tract antigen presenting cell populations. In: Annual meeting of the American Thoracic Society. USA - San Francisco: Annual meeting of the American Thoracic Society

Blank, F; Strickland, D; Stumbles, Ph; Holt, P; von Garnier, C (2011). Particle size determines uptake efficiency of different antigen presenting cell populations in the respiratory tract during steady state and allergic airways inflammation. In: SGP-Jahreskongress 2011. SGP-Jahreskongress 2011

Strickland, DH; Blank, F; Wikstrom, M; Smith, M; Thomas, JA; Rothen-Rutishauser, B; Holt, P; Stumbles, Ph; von Garnier, C (2011). Resident common precursors for dendritic cells and macrophages in the lung parenchyma. In: Jahreskongress American Thoracic Society. Jahreskongress American Thoracic Society

Blank, F; Strickland, DH; Stumbles, Ph; Holt, P; von Garnier, C (2011). Different antigen presenting cell populations in the respiratory tract show size dependent particle uptake efficiency during steady state and allergic airways inflammation. In: Jahreskongress European Respiratoy Society. Amsterdam: Jahreskongress European Respiratoy Society

Vogel, R; Blank, F; Gazdhar, A; Widmer, HR; Geiser, T; von Garnier, C (2011). Systemic distribution of biomedical nanoparticles applied via the pulmonary route. In: SGP-Jahreskongress 2011. SGP-Jahreskongress 2011

Huguenot, M; Blank, F; von Garnier, C (2011). Commercial surfactant modulates dendritic cell phenotype and functionality. In: SGP-Jahreskongress 2011. SGP-Jahreskongress 2011

Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: , (ed.) Swiss Society for Pneumology. Lausanne: Swiss Society for Pneumology

Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: European Respiratory Society Annual Conference. Barcelona, Spain: European Respiratory Society Annual Conference

Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: 11th International Symposium on dendritic cells in fundamental and clinical immunology. Lugano.

Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: Day of clinical research at the Bern University. Bern: Day of clinical research at the Bern University

Blank, F; von Garnier, C; Dumont, P; Sauter, K; Loosli, RH; Geiser, T (2010). High diagnostic yield of EBUS guided TBNA in the diagnosis of centrally located intrapulmonary lesions. In: Schweizerische Gesellschaft für Pneumologie. Orlando: Schweizerische Gesellschaft für Pneumologie

Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, V; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2009). Dendritic cells exposed to biomedical nanoparticles retain an immature like functional state and show reduced antigen specific CD4+ T cell stimulation in vitro. In: Conference of the American Thoracic Society. San Diego.

von Garnier, C; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T (2009). Exposure of dendritic cells to biomedical nanoparticles down-regulates antigen-specific CD4+ T cell stimulation. In: International conference of the European Respiratory Society. Wien.

This list was generated on Mon Aug 26 05:34:37 2019 CEST.
Provide Feedback